Candriam SCA’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $33.5M | Sell |
324,260
-61,542
| -16% | -$5.49M | 0.15% | 142 |
|
|
2026
Q1 | $27.7M | Hold |
385,802
| – | – | 0.14% | 151 |
|
|
2025
Q4 | $30.6M | Buy |
385,802
+194,844
| +102% | +$15.4M | 0.15% | 141 |
|
|
2025
Q3 | $14.4M | Sell |
190,958
-37,430
| -16% | -$2.57M | 0.08% | 219 |
|
|
2025
Q2 | $15.8M | Sell |
228,388
-5,703
| -2% | -$374K | 0.09% | 195 |
|
|
2025
Q1 | $15.9M | Buy |
234,091
+123,891
| +112% | +$7.41M | 0.1% | 186 |
|
|
2024
Q4 | $4.95M | Buy |
110,200
+13,040
| +13% | +$732K | 0.03% | 358 |
|
|
2024
Q3 | $6.11M | Buy |
97,160
+755
| +0.8% | +$44K | 0.04% | 332 |
|
|
2024
Q2 | $5.69M | Sell |
96,405
-195,007
| -67% | -$12.2M | 0.03% | 322 |
|
|
2024
Q1 | $23.2M | Sell |
291,412
-141,201
| -33% | -$10.8M | 0.15% | 147 |
|
|
2023
Q4 | $34.2M | Buy |
432,613
+173,041
| +67% | +$12.3M | 0.24% | 97 |
|
|
2023
Q3 | $18.1M | Sell |
259,572
-47,200
| -15% | -$3.34M | 0.13% | 155 |
|
|
2023
Q2 | $21.2M | Sell |
306,772
-210,940
| -41% | -$15M | 0.15% | 152 |
|
|
2023
Q1 | $35.4M | Sell |
517,712
-169,870
| -25% | -$14.2M | 0.25% | 99 |
|
|
2022
Q4 | $64.1M | Sell |
687,582
-44,969
| -6% | -$4.34M | 0.43% | 53 |
|
|
2022
Q3 | $69.9M | Buy |
732,551
+158,377
| +28% | +$15.7M | 0.49% | 42 |
|
|
2022
Q2 | $53.2M | Buy |
574,174
+112,887
| +24% | +$11M | 0.44% | 56 |
|
|
2022
Q1 | $46.7M | Buy |
461,287
+124,303
| +37% | +$13.1M | 0.32% | 76 |
|
|
2021
Q4 | $34.8M | Buy |
336,984
+1,686
| +0.5% | +$156K | 0.22% | 119 |
|
|
2021
Q3 | $28.5M | Buy |
335,298
+7,166
| +2% | +$600K | 0.19% | 124 |
|
|
2021
Q2 | $27.9M | Buy |
328,132
+78,903
| +32% | +$6.46M | 0.19% | 122 |
|
|
2021
Q1 | $16.3M | Buy |
249,229
+9
| +0% | +$656 | 0.14% | 170 |
|
|
2020
Q4 | $17M | Buy |
249,220
+43,162
| +21% | +$2.81M | 0.13% | 171 |
|
|
2020
Q3 | $12M | Buy |
206,058
+32,681
| +19% | +$2.03M | 0.11% | 201 |
|
|
2020
Q2 | $11.3M | Buy |
173,377
+4,959
| +3% | +$312K | 0.12% | 200 |
|
|
2020
Q1 | $12.2M | Buy |
168,418
+20
| +0% | +$1.33K | 0.14% | 174 |
|
|
2019
Q4 | $12.5M | Buy |
168,398
+17,700
| +12% | +$1.24M | 0.13% | 175 |
|
|
2019
Q3 | $9.51M | Buy |
150,698
+35,533
| +31% | +$2.11M | 0.13% | 194 |
|
|
2019
Q2 | $7.34M | Sell |
115,165
-39,710
| -26% | -$2.14M | 0.09% | 247 |
|
|
2019
Q1 | $9.43M | Sell |
154,875
-5,727
| -4% | -$353K | 0.12% | 202 |
|
|
2018
Q4 | $10.5M | Sell |
160,602
-6,094
| -4% | -$455K | 0.16% | 148 |
|
|
2018
Q3 | $13.1M | Buy |
166,696
+63,531
| +62% | +$4.54M | 0.17% | 144 |
|
|
2018
Q2 | $6.64M | Buy |
103,165
+8,519
| +9% | +$561K | 0.11% | 245 |
|
|
2018
Q1 | $5.89M | Sell |
94,646
-2,102
| -2% | -$151K | 0.1% | 251 |
|
|
2017
Q4 | $7.01M | Buy |
96,748
+5,986
| +7% | +$435K | 0.12% | 208 |
|
|
2017
Q3 | $7.38M | Sell |
90,762
-4,691
| -5% | -$371K | 0.13% | 199 |
|
|
2017
Q2 | $7.68M | Buy |
95,453
+3,314
| +4% | +$262K | 0.14% | 176 |
|
|
2017
Q1 | $7.23M | Buy |
92,139
+14,012
| +18% | +$1.12M | 0.14% | 188 |
|
|
2016
Q4 | $6.17M | Sell |
78,127
-64,296
| -45% | -$5.2M | 0.14% | 181 |
|
|
2016
Q3 | $12.7M | Buy |
142,423
+46,106
| +48% | +$4.35M | 0.3% | 80 |
|
|
2016
Q2 | $9.22M | Buy |
96,317
+12,096
| +14% | +$1.21M | 0.24% | 109 |
|
|
2016
Q1 | $8.69M | Sell |
84,221
-68,115
| -45% | -$6.62M | 0.22% | 123 |
|
|
2015
Q4 | $14.9M | Buy |
152,336
+24,800
| +19% | +$2.43M | 0.4% | 60 |
|
|
2015
Q3 | $12.3M | Buy |
127,536
+48,088
| +61% | +$5.06M | 0.3% | 96 |
|
|
2015
Q2 | $8.33M | Buy |
79,448
+19,786
| +33% | +$2.02M | 0.17% | 166 |
|
|
2015
Q1 | $6.16M | Buy |
59,662
+5,632
| +10% | +$570K | 0.12% | 215 |
|
|
2014
Q4 | $5.2M | Buy |
+54,030
| New | +$4.76M | 0.11% | 223 |
|
Other funds holding CVS
Candriam SCA's CVS Position: Q2 2026 in Review
Candriam SCA reduced its CVS Health (CVS) stake by 16% in Q2 2026, selling an estimated $5.49M and leaving 324,260 shares worth $33.5M. The position accounts for 0.15% of the portfolio, ranked #142.
Candriam SCA first reported a position in CVS in Q4 2014 and has held it in 47 quarters since. The position peaked at $69.9M in Q3 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Candriam SCA held 324,260 shares of CVS Health worth $33.5M as of Q2 2026.
- Candriam SCA sold 61,542 CVS Health shares in Q2 2026, an estimated $5.49M.
- CVS Health made up 0.15% of Candriam SCA's portfolio in Q2 2026, its #142 holding.
- Candriam SCA first reported a position in CVS Health in Q4 2014 and has held it in 47 quarters since.
- Candriam SCA's CVS Health position peaked at $69.9M in Q3 2022.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.